BioSpace News Archive

Amarin Corporation plc (NASDAQ:AMRN) today announced that John F. Thero, Amarin’s president and chief executive officer, is scheduled to present general company updates at two upcoming investor conferences

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, today announced that the investigator-initiated expanded access protocol using its cryopreserved allogeneic cell therapy product candidate remestemcel-L for steroid-refractory chronic graft versus host disease (chronic GVHD) has resulted in clinically meaningful outcomes in all three treated patients, two children and one adult, within 28 days after two infusions.

Delta Dental released new findings from its Original Tooth Fairy Poll® that show a 30-cent increase in the Tooth Fairy’s average cash gift for a total of $4.03 per tooth.

i:X Platform’s Precise Wound Measurement, along with Fluorescence Imaging, for More Accurate Detection and Ongoing Documentation of Wounds

MEDNAX, Inc. (NYSE: MD), the national health solutions partner specializing in neonatology, anesthesiology, radiology, maternal-fetal medicine, and other pediatric services, today reported earnings from continuing operations of $0.40 per share for the three months ended December 31, 2019

Dyve Biosciences, a research and drug development company using proprietary science to create novel therapeutics, today announced it has enrolled its first patient in TARGETS, a Phase 2 clinical study of DYV-700, the company’s topically administered therapeutic being developed as a treatment for acute gout.

Viz.ai, Inc., the leading applied artificial intelligence healthcare company, is excited to highlight Dr. Vitor Mendes Pereira’s presentation “Artificial Intelligence to Improve the Detection and Triage of Cerebral Aneurysms”, which outlines the development of the Viz.ai algorithm to detect cerebral aneurysms at the International Stroke Conference in Los Angeles on Thursday at 4:15pm PST in Room 515B..

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced ten scientific studies utilizing the GeoMx™ Digital Spatial Profiler (DSP) that will be showcased at the 2020 Advances in the Genome Biology and Technology (AGBT) conference being held at the JW Marriott in Marco Island, Florida.

Bluestar Adisseo Company, a world leader in feed additives for animal nutrition, and the world’s leading alternative protein producer, Calysta, signed an agreement to establish a joint venture named Calysseo to develop FeedKind®, an innovative feed solution for aquaculture, and to provide exclusive supply for Asian markets.

Syneos Health (Nasdaq:SYNH), a leading biopharmaceutical solutions organization combining a Contract Research Organization and a Contract Commercial Organization, today reported financial results for the three and twelve months ended December 31, 2019.